AU1345900A - Oxazolidinones useful as alpha 1a adrenoceptor antagonists - Google Patents

Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Info

Publication number
AU1345900A
AU1345900A AU13459/00A AU1345900A AU1345900A AU 1345900 A AU1345900 A AU 1345900A AU 13459/00 A AU13459/00 A AU 13459/00A AU 1345900 A AU1345900 A AU 1345900A AU 1345900 A AU1345900 A AU 1345900A
Authority
AU
Australia
Prior art keywords
alpha
adrenoceptor antagonists
oxazolidinones useful
oxazolidinones
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13459/00A
Inventor
Mark G. Bock
Jennie B. Nerenberg
Linda Payne
Harold G. Selnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU1345900A publication Critical patent/AU1345900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
AU13459/00A 1998-11-10 1999-11-09 Oxazolidinones useful as alpha 1a adrenoceptor antagonists Abandoned AU1345900A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10783998P 1998-11-10 1998-11-10
US60107839 1998-11-10
US19050698A 1998-11-12 1998-11-12
US09190506 1998-11-12
PCT/US1999/026437 WO2000027827A1 (en) 1998-11-10 1999-11-09 Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Publications (1)

Publication Number Publication Date
AU1345900A true AU1345900A (en) 2000-05-29

Family

ID=26805221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13459/00A Abandoned AU1345900A (en) 1998-11-10 1999-11-09 Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Country Status (2)

Country Link
AU (1) AU1345900A (en)
WO (1) WO2000027827A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290549B (en) * 2000-06-02 2007-12-01 Astrazeneca Ab Process for the preparation of cyclopropyl carboxylic acid ester and derivatives
JP2012511007A (en) * 2008-12-04 2012-05-17 グラクソ グループ リミテッド Method for preparing spiroindoline and its precursor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3011299A (en) * 1998-03-23 1999-10-18 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia

Also Published As

Publication number Publication date
WO2000027827A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
AU4423499A (en) Novel analgesic agents
AU8441798A (en) Tricyclically substituted oxazolidinones
AU5227999A (en) Substituted oxazolines as antiproliferative agents
AU4318000A (en) Agarobiose-containing composition
AU4431000A (en) Novel use
AU2616199A (en) Novel bicyclene-substituted oxazolidinones
IL130024A0 (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
AU5970699A (en) Use
AU1290501A (en) Composition
AU3472600A (en) Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
IL130094A0 (en) 2-Imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
IL148275A0 (en) Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors
AU2656799A (en) Metal-thiols as imminomodulating agents
AU1406001A (en) Auto-adhesive composition
AU1345600A (en) Pyrimidinedione derivatives useful as alpha 1a adrenoceptor antagonists
AU2031701A (en) Toothbrush device
AU1345900A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
GB9810180D0 (en) Novel formulation
AU6310600A (en) Composition
AU5433898A (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists
AU6994600A (en) Substituted benzoxazoles
IL130067A0 (en) 2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
AU2594399A (en) Components with releasable leads
AU1345800A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
AU1346000A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase